Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ashley Blurton (NPI 1295908077)

Field	Value
Entity Type	Individual
Organization	Ashley Blurton
Address	78 Medical Center Dr
City	Fishersville
State	VA
ZIP	22939
Taxonomy	Nuclear Medicine Physician
NPI Enumerated	April 11, 2008

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider’s Medicare activity is highly concentrated in PET radiopharmaceutical imaging: A9595 (Piflufolastat f-18) alone accounts for $2M in Medicare revenue, 4.4K claims and a $464 avg paid/claim, representing 69.6% of the provider’s total Medicare revenue. The top three Medicare codes together account for 100.0% of Medicare revenue, indicating a narrowly focused diagnostic imaging practice rather than a broad multispecialty billing profile.

Business/service-line profile points to a nuclear medicine/PET-focused operation: the presence and volumes of A9595 and A9596 (Gallium ga-68 gozetotide) alongside high-volume PET/CT reporting under 78815 suggest the provider delivers advanced PET diagnostics — including PSMA-targeted imaging and Ga-68–based studies — and likely operates a dedicated PET service or referral center for these radiotracers. The $672.8K tied to 78815 (576 claims, $1168 avg paid/claim) confirms substantial PET/CT procedure throughput supporting the radiopharmaceutical volumes.

Revenue concentration risk/opportunity is pronounced: with the top three codes making up 100.0% of Medicare revenue and A9595 contributing 69.6%, the provider’s Medicare revenue stream is dependent on a very small set of services. Any changes in utilization, reimbursement, or access to these specific radiopharmaceuticals would disproportionately affect total Medicare earnings ($2.9M reported).

Competitive standing for A9595 is nationally extreme: the provider ranks #2 of 528 providers nationally for A9595 (100th percentile; described as an "extreme outlier" and far above typical national volume for this code), indicating national-scale dominance in billing volume for piflufolastat PET among peers. The provider’s position on 78815 is also strong regionally/nationally (#159 of 6566, 98th percentile; "notably above typical national volume"), showing above-average PET/CT throughput compared with most peers.

By contrast, A9596 volume is typical rather than exceptional: A9596 accounts for $210.8K (251 claims, $840 avg paid/claim) and ranks #42 of 168 providers nationally (75th percentile), which the peer data labels as a typical, unremarkable volume for this code. This suggests that while the provider is a leader in PSMA-targeted imaging (A9595), its use of Ga-68 gozetotide is within a common range among specialized providers.

Payer mix is effectively single-payer with respect to public programs: the record shows Total Medicare revenue of $2.9M and "none below" for Medicaid — there is no Medicaid billing on file. Analysts should treat this provider as Medicare-centric when modeling public-payer exposure or network participation risk.

Tenure and stability: the provider’s NPI was enumerated on 2008-04-11 (~18 years ago), indicating long-standing enrollment in federal programs; combined with concentrated, high-volume specialty billing, this suggests an established clinical operation focused on nuclear medicine PET services. The sustained high volumes in a limited set of advanced imaging codes imply an operational specialization rather than recent ramp-up.

From a strategic/market perspective, the provider is a specialized, high-volume PET radiopharmaceutical operator: dominance in A9595 plus substantial 78815 throughput positions the provider as a major referral or service destination for PSMA PET imaging. For payers and competitors, the profile signals a niche leader in advanced prostate and tumor PET diagnostics with limited diversification into other billed services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

3 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
A9595	Piflufolastat f-18, diagnostic, 1 millicurie	4,370	$460	$2M
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	580	$1,170	$672.8K
A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	250	$840	$210.8K

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Ashley Blurton — 3 of 3 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

3 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
A9595	1	10	120	$540	$325.9K
A9596	1	10	140	$850	$128.8K
78815	3	130	80	$410	$55.5K

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ashley Blurton, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mcv Associated Physicians	VA	Anesthesiology Physician	$0	$99M
University Of Virginia Physicians Group	VA	Sports Medicine (Neuromusculoskeletal Medicine) Physician	$0	$84.6M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Augusta Medical Group	VA	General Practice Physician	$0	$12.6M
Med Atlantic Inc	VA	Ambulatory Surgical Clinic/Center	$4.9M	$298.7K
Mohit Nanda	VA	Retina Specialist (Ophthalmology) Physician	$4.6M	$0
Robert Olk	MO	Ophthalmology Physician	$1.7M	$0
Shaya Ansari	NY	Diagnostic Radiology Physician	$1.5M	$1K
Yevgeniy Shildkrot	VA	Ophthalmology Physician	$1.5M	$0
Nader Moinfar	VA	Ophthalmology Physician	$1.4M	$0

Nearby Providers

Other providers in the same ZIP code as Ashley Blurton, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Augusta Health Care, Inc	VA	General Acute Care Hospital	$0	$63.6M
Shenandoah Emergency Medicine Specialists LLC	VA	Emergency Medicine Physician	$0	$7.5M
Shil Patel	VA	Ophthalmology Physician	$6.1M	$0
Blue Ridge Pathologists PC	VA	Anatomic Pathology Physician	$224.6K	$1.2M
James Tiedeman	VA	Ophthalmology Physician	$782.7K	$0
William Jones	VA	Urology Physician	$468.4K	$0
David Barnes	VA	Specialist	$405.8K	$150
Rachna Patel	VA	Specialist	$377K	$0
Glenn Brammer	VA	Clinical Cardiac Electrophysiology Physician	$375.6K	$0
Brian Stisser	VA	Urology Physician	$326.4K	$0

Ashley Blurton — Billing Profile & Reimbursement Data

Sign up for Ashley Blurton — Billing Profile & Reimbursement Data policy alerts

Ashley Blurton — Billing Profile & Reimbursement Data

Sign up for Ashley Blurton — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References